e-learning
resources
Virtual 2020
Pre-Congress Content
Smoking disease landscape: from inflammation to lung function and comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical, Functional and Radiological Findings in Smokers with Mild COPD: what lies behind FEV1/FVC Ratio less than 70%
M. Vershinina (Omsk, Russian Federation), A. Khomenya (Omsk, Russian Federation), O. Foronosova (Omsk, Russian Federation)
Source:
Virtual Congress 2020 – Smoking disease landscape: from inflammation to lung function and comorbidities
Session:
Smoking disease landscape: from inflammation to lung function and comorbidities
Session type:
E-poster session
Number:
1318
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Vershinina (Omsk, Russian Federation), A. Khomenya (Omsk, Russian Federation), O. Foronosova (Omsk, Russian Federation). Clinical, Functional and Radiological Findings in Smokers with Mild COPD: what lies behind FEV1/FVC Ratio less than 70%. 1318
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Dynamic Chest Radiography Measured Postretoanterior Total Lung Area Correlates with FEV1 in Healthy Volunteers and COPD Patients
Source: International Congress 2019 – Lung function and respiratory muscle testing
Year: 2019
COPD or not COPD: Answer in FEV1
Source: International Congress 2016 – From cardiopulmonary interaction to locomotor muscles and dyspnoea in health and disease
Year: 2016
Safety and Feasibility of Metered CryoSpray (MCS) for Patients with Chronic Bronchitis in COPD: 9 Month Results.
Source: International Congress 2019 – Bronchoscopic treatment of COPD: hot news
Year: 2019
Usefulness of FEV1/SVC to uncover airflow obstruction in subjects with preserved FEV1/FVC
Source: International Congress 2016 – Lung function and imaging: new findings and new approaches
Year: 2016
Heterogeneous causes and degree of exercise limitation in COPD GOLD1 and 2: Predictive value of CCQ and MRC
Source: Annual Congress 2011 - Clinical physiology for clinical problems
Year: 2011
COPD: Pulmonary damage beyond FEV1
Source: International Congress 2014 – Diagnosis and treatment of COPD in primary care
Year: 2014
Mortality after COPD-exacerbations: Learning from epidemiology
Source: International Congress 2014 – Clinical presentations
Year: 2014
Severity of airflow obstruction using NHANESIII versus ERS/GLI12 prediction equations in Caucasian American pulmonary laboratory patients
Source: International Congress 2014 – The impact of the Global Lung Initiative (GLI) reference equations and spirometry quality in all ages
Year: 2014
LATE-BREAKING ABSTRACT: Clinical and Epidemiological Characteristics of Hospitalized COPD Exacerbations.
Source: International Congress 2014 – Predictors
Year: 2014
LATE-BREAKING ABSTRACT: The impact of Global Lung Initiative (GLI) implementation in a cohort of patients over the age of 70 years.
Source: International Congress 2014 – Innovative technology and techniques in respiratory function
Year: 2014
Concordance among GOLD, NICE and LLN criteria in the spirometry diagnosis of airflow obstruction
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
Lung function testing in the elderly – can we still use FEV1/FVC < 70% as a criterion of COPD?
Source: Eur Respir J 2006; 28: Suppl. 50, 613s
Year: 2006
Natural decline in FEV
1
and FVC: Self versus reference equations
Source: Annual Congress 2013 –Reference, reliability and risk: advances in lung function
Year: 2013
Agreement Between COPD Assessment Test (CAT) And Modified Medical Research Council (mMRC) Dyspnea Scores For GOLD COPD Classification: A Cross-Sectional Analyses
Source: International Congress 2019 – Clinical implications of COPD management
Year: 2019
Assessment of lung function in symptomatic and asymptomatic smokers without Chronic Obstructive Pulmonary Disease (COPD) using the Impulse Oscillatory Technique (IOT)
Source: Virtual Congress 2020 – Health effects of inhaled nicotine devices: from smoking to vaping and heated tobacco
Year: 2020
Examination of patients whose eosinophilic ratio in sputum was more than 3% with wheezing or cough symptoms
Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura
Year: 2014
Global Lung Function Initiative equations improve interpretation of FEV1 decline among patients with cystic fibrosis
Source: Eur Respir J 2015; 46: 262-264
Year: 2015
Fixed ratio or lower limit of normal for the FEV1/VC ratio: Relation to symptoms and extended lung function tests
Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population
Year: 2013
LCI as an endpoint in COPD: Comparison with healthy controls, using SF
6
and nitrogen washout
Source: International Congress 2014 – Respiratory function: quality and new technologies
Year: 2014
Quantitative Functional Respiratory Imaging may predict the mechanism of FEV1 Decline after Lung Transplantation
Source: International Congress 2017 – Lung transplant outcomes
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept